Traditional healthcare SaaS means software programs provided over the internet that help with healthcare tasks like electronic health records (EHRs), managing practices, billing, and scheduling. Healthcare organizations usually have to operate the software, train their staff, and connect these systems with what they already use. They make money mostly by charging subscription fees or licensing per user.
AI Services-as-Software, on the other hand, uses artificial intelligence to automate difficult healthcare tasks. Instead of just providing software, AI SaaS handles tasks on its own that used to need a lot of human work. Examples include automatic clinical notes, checking claims, scheduling surgeries, and managing pharmacy back-office work. This kind of AI software often works as a full service with AI systems doing most of the work and people stepping in only when needed to check quality.
The speed at which these two models are growing is very different. According to a 2024 report by Bessemer Venture Partners, AI healthcare companies got about 38% of new investment money. This shows a clear move toward AI solutions. AI SaaS companies usually find their market and start growing revenue faster than traditional healthcare SaaS companies.
AI SaaS firms can grow to $10 million in yearly recurring revenue much quicker than the traditional SaaS firms. This fast growth happens for several reasons:
Traditional healthcare SaaS companies often grow slower because they need complex system integration, face user resistance, and deal with long buying processes. These make product adoption take longer and slow down revenue growth.
Sales cycles, or the time from the first contact to closing a deal, also differ between these service types. This is important for the financial health and growth of healthcare software companies.
Traditional healthcare SaaS companies in the U.S. have sales cycles that last from 12 to 18 months. These long sales take time because many people have to approve, there are long pilot tests and trials, regulatory rules must be followed, and healthcare organizations need customized setups.
AI Services-as-Software companies usually close deals in less than six months. This happens because:
AI SaaS companies also onboard customers more quickly, helping them earn revenue faster than healthcare SaaS firms that spend longer on customization and integration.
The way these companies make money is also different.
Traditional healthcare SaaS makes money by charging for user licenses, subscriptions, or access to different features. Customers pay regularly based on how many users or software parts they use. This fits IT budgets well but can limit big deals because IT spending is often tight in medical offices.
AI Services-as-Software often charges based on the value or results provided. For example:
This fits how healthcare operations spend money, usually on outside service contracts instead of software licenses. These contracts tend to be bigger, come from operations budgets, and allow higher prices. Because of this, AI SaaS companies have higher company value multiples—2 to 5 times more than traditional healthcare SaaS firms, with earnings multiples from 30x to 50x EV/ARR.
AI-driven workflow automation is changing how healthcare providers and managers handle front-office and back-office tasks. Medical administrators, owners, and IT managers in the U.S. use AI SaaS more to reduce mistakes, speed up work, and let clinical staff focus less on admin duties.
Common Application Areas:
These AI automations take over repetitive tasks, so healthcare staff can focus more on patient care and harder decisions. Automation also lowers costs related to worker shortages, common in many U.S. clinics.
The U.S. healthcare system struggles with admin inefficiency, which adds to high operational costs. AI SaaS offers relief by automating work and using human checks only when needed. This keeps work accurate while handling more volume without raising costs in the same way.
Medical administrators and IT managers face daily problems with workflow, rules, and budgets. Choosing between traditional healthcare SaaS and AI SaaS affects how they run and pay for their systems.
AI Services-as-Software is growing in healthcare to help reduce admin costs, deal with labor shortages, and make operations stronger.
This comparison aims to help medical practice administrators, owners, and IT managers in the U.S. make smart choices about using AI technologies. Picking between traditional healthcare SaaS and AI SaaS means thinking about speed, cost, buying processes, and how well each fits the organization. Using AI automation for things like front-office calls and back-office claims work gives practical ways to improve efficiency and patient service while managing expenses.
AI Services-as-Software leverage AI to autonomously perform tasks traditionally done by humans, delivering outcomes rather than just software tools. This model streamlines complex administrative workflows across providers, payers, and pharma, addressing the $1 trillion administrative spend and healthcare labor shortage by automating tasks like medical documentation, claims auditing, and back-office operations.
AI Services-as-Software show faster go-to-market trajectories and growth rates than traditional SaaS. They often sell outcomes, tapping larger budgets and bypassing long change management cycles by outsourcing end-to-end workflows, resulting in shorter sales cycles (<6 months) versus traditional 12-18 months and higher contract values.
There are three: Copilots, which augment and automate worker tasks; AI-first services, which fully outsource services with human-in-the-loop for quality assurance; and Agents, which aim to fully automate workflows, though fully autonomous agents in healthcare are still in development.
COGS drivers include AI model costs, computational resources, and human-in-the-loop expenses for quality assurance and reinforcement learning. Despite variability (10%-90% gross margins), average gross margins hover around 60-65%, reflecting differences in complexity, accuracy needs, and scale economies.
In 2024, 38% of healthcare investments targeted AI solutions, often yielding valuation multiples 2-5x higher than non-AI peers. This is fueled by large market potential, new business models, and urgent demand for AI to reduce costs and improve ROI in provider, payer, and pharma workflows.
Early-stage ventures struggle particularly at Series A and B funding rounds with longer times to raise capital, compared to other sectors, making efficient growth, cash preservation, and proving product-market fit critical for success in a tougher financing environment.
Emerging trends include payer administration insourcing using AI Services-as-Software, transparency tooling in pharmacy pricing and rebate management, AI-assisted clinical services to empower providers, and technologies enabling value-based care systems of record to support risk models and outcome measurement.
Instead of per-seat or license fees, these companies often get paid based on units of value delivered or outcomes, aligning with large OpEx and services budgets rather than IT budgets, facilitating procurement and potentially commanding premium pricing.
Examples include Abridge, automating clinical note generation; SmarterDx, AI-powered clinical review of medical claims; Qventus, automating surgery scheduling; and Plenful, focusing on back-office automation for specialty pharmacies.
AI Services-as-Software reduce the burden of repetitive administrative tasks on healthcare staff, allowing workforce reallocation to areas demanding human expertise while cutting operational costs in time-consuming processes like medical scribing, coding, and claims management.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
